5.1

CVE-2026-94033: sourcecodester drug recommendation system Cross-site Scripting

CVSS: 5.1v4.0MediumDeferred
Published 20-09-2026Last modified 17-10-2026

Vulnerability summary

CVE-2026-94033 is a medium (CVSS 5.1) Cross-site Scripting vulnerability in sourcecodester drug recommendation system. EPSS estimates a 0.35% chance of exploitation in the next 30 days, higher than 26.9% of scored vulnerabilities. 1 public exploit is recorded.

Overall risk
30/100
0100
Medium · default modelHow is this calculated?
CVSS score
5.1/10
010
Medium · v4.0 (CVE.org)
EPSS score
0.35%
0%100%
Low · Change unavailable
KEVNot listedIn no KEV catalog
RansomwareNone recordedNo known use recorded
Public exploits1github

Timeline

  1. 20-09-2026
    PublishedVulnerability first disclosed.
  2. 17-10-2026
    Last modifiedVulnerability information updated.

Description

A vulnerability has been found in SourceCodester Drug Recommendation System 1.0. This vulnerability affects unknown code of the file /drug_recommender/Admin/add_user of the component User Management. Such manipulation of the argument txtname/txtemail/txtpassword leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used.

CVSS metrics

7 scores · 2 sources · 4 versions

EPSS trend

Probability

0.35%

Chance of exploitation in the next 30 days

Percentile

27%

Versus all other CVEs

30-day change

Change unavailable

Change unavailable

21-09-202619-10-2026
EPSS score
0.35%

Known exploited

Compare KEV catalogs

Not in any of the 3 tracked catalogs.

Public exploits

1 found
  • githubUnverified

    Drug Recommendation System

    Maturity: poc

Weaknesses

CWE · root cause

Affected systems

Sourcecodester1 product

1 vendor · 1 product

References

6 links